SA96: an immunopharmacological profile in vitro

Area of Science:

• Immunopharmacology
• Cellular immunology

Background:

• Thiol compounds are investigated for immunomodulatory properties.
• Understanding novel stimulants of lymphocyte proliferation is crucial for developing new therapeutics.

Purpose of the Study:

• To screen thiol compounds for their ability to stimulate lymphocyte proliferation.
• To characterize the immunopharmacological profile of SA96 in vitro.
• To assess SA96's effect on T-dependent and T-independent immune responses.

Main Methods:

• Screening of thiol compounds to identify SA96.
• In vitro assessment of SA96's effect on lymphocyte proliferation induced by lipopolysaccharide (LPS) and concanavalin A (Con A).
• Evaluation of SA96's impact on plaque-forming cell (PFC) responses to sheep red blood cells (SRBC) and DNP-Ficoll in the presence or absence of 2-mercaptoethanol (2-ME).

Main Results:

• SA96 at 10(-3) M concentration induced 3H-thymidine uptake in murine lymphocytes.
• SA96 exhibited biphasic effects on mitogen-induced proliferation, suppressing responses below 10(-4) M but enhancing LPS-induced proliferation at 10(-3) M.
• SA96 enhanced T-independent PFC responses to DNP-Ficoll and T-dependent PFC responses to SRBC at non-mitogenic doses (10(-5) to 10(-4) M).

Conclusions:

• SA96, a thiol compound, demonstrates immunomodulatory activity.
• The cysteine moiety in SA96 may contribute to its proliferative effects.
• SA96 shows potential as an immunomodulator, comparable to levamisole.